Přejít k obsahu
Merck
  • Differential interactions of rifabutin with human and bacterial membranes: implication for its therapeutic and toxic effects.

Differential interactions of rifabutin with human and bacterial membranes: implication for its therapeutic and toxic effects.

Journal of medicinal chemistry (2012-12-12)
Marina Pinheiro, Mariana Arêde, Cláudia Nunes, João M Caio, Cristina Moiteiro, Marlene Lúcio, Salette Reis
ANOTACE

This work focuses on the interaction of rifabutin (RFB), a naphthalenic ansamycin, with membrane models. Since the therapeutic and toxic effects of this class of drugs are strongly influenced by their lipid affinity, we concerned specifically on the ability of this antibiotic to affect the membrane biophysical properties. The extent of the interaction between RFB and membrane phospholipids was quantified by the partition coefficient (K(p)), using membrane model systems that mimic the human (liposomes of 1,2-dimyristoyl-sn-glycero-phosphocholine, DMPC) and the bacterial (liposomes of 1,2-dimyristoyl-sn-glycero-3-phosphoglycerol, DMPG) plasma membranes. To predict the drug location in the membranes, fluorescence quenching and lifetime measurements were carried out using the above-mentioned membrane models labeled with fluorescent probes. Steady-state anisotropy measurements were also performed to evaluate the effect of RFB on the microviscosity of the membranes. Overall, the results support that RFB has higher affinity for the bacterial membrane mediated by electrostatic interactions with the phospholipid head groups.

MATERIÁLY
Číslo produktu
Značka
Popis produktu

Sigma-Aldrich
Rifabutin, >98% (HPLC), powder